draft standards for faecal microbiota transplant (fmt ... draft standards for faecal microbiota...

Download Draft standards for faecal microbiota transplant (FMT ... Draft Standards for Faecal microbiota transplant

Post on 13-Jul-2020

0 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

  • Draft standards for faecal microbiota transplant (FMT) products Consultation paper

    Version 1.0, November 2019

  • Options for the regulation of Faecal Microbiota Transplantation materials V1.0 January 2019

    Page 2 of 69

    Copyright © Commonwealth of Australia 2019 This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given specific written permission from the Commonwealth to do so. Requests and inquiries concerning reproduction and rights are to be sent to the TGA Copyright Officer, Therapeutic Goods Administration, PO Box 100, Woden ACT 2606 or emailed to

    Confidentiality All submissions received will be placed on the TGA’s Internet site, unless marked confidential. Any confidential material contained within your submission should be provided under a separate cover and clearly marked ‘IN CONFIDENCE’. Reasons for a claim to confidentiality must be included in the space provided on the TGA submission form. For submission made by individuals, all personal details, other than your name, will be removed from your submission before it is published on the TGA’s Internet site. In addition, a list of parties making submissions will be published. If you do not wish to be identified with your submission you must specifically request this in the space provided on the submission form.

    mailto:tga.copyright@tga.gov.au

  • Therapeutic Goods Administration

    Draft Standards for Faecal microbiota transplant (FMT) products V1.0 November 2019

    Page 3 of 69

    Contents Purpose and scope _____________________________ 5 Background ___________________________________ 5 FMT standards _________________________________ 7

    Background _____________________________________________________________________ 7 Australian setting ______________________________________________________________ 8 Australian Consensus Working Group ______________________________________ 8 Other jurisdictions _____________________________________________________________ 8 Commencement of draft TGO ________________________________________________ 9 Demonstrating compliance _________________________________________________ 10 Consultation __________________________________________________________________ 10

    Appendix 1: Guidance on draft Therapeutic Goods (Standard for FMT Products) Order _______________ 11 Part 2 – General requirements ___________________ 11

    Section 7 General requirements for FMT products _____________________ 11 Subsection 1 Collection and manufacture ------------------------------------------- 11

    Subsection 2 Manufacturing facilities ------------------------------------------------ 12

    Subsection 4 Critical materials --------------------------------------------------------- 15

    Part 3 – Specific requirements ___________________ 15 Section 8 Medical and social history of prospective stool donors ____ 15

    Subsection 1 Donor interview ---------------------------------------------------------- 16

    Subsection 3 Ineligibility criteria ----------------------------------------------------- 17

    Subsection 4 Autologous use ----------------------------------------------------------- 33

    Subsection 5 Changing donor criteria for banked FMT products ------------- 33

    Subsection 6 Exemptions of donor criteria ----------------------------------------- 34

    Subsection 7 Age limits ------------------------------------------------------------------- 36

    Section 9 Donor blood and stool testing __________________________________ 36 Subsection 1 Collection and testing: general --------------------------------------- 36

    Subsections 2 and 3 Collection and testing of blood and stool samples ---- 37

    Subsection 4 Collection and testing: timing ---------------------------------------- 40

    Subsection 5 Test kits / methodologies --------------------------------------------- 40

    Subsection 6 Service agreements with testing labs ------------------------------ 42

  • Therapeutic Goods Administration

    Draft Standards for Faecal microbiota transplant (FMT) products V1.0 November 2019

    Page 4 of 69

    Subsection 9 Blood (serum / plasma) and stool archiving --------------------- 43

    Subsection 11 Results of tests: recording ------------------------------------------- 44

    Section 10 Donor physical assessment and testing _____________________ 44 Subsection 2 Donor physical assessment ------------------------------------------- 44

    Subsection 3 Repeat clinical assessment -------------------------------------------- 45

    Subsection 4 Donor blood sample testing ------------------------------------------- 45

    Subsection 5 Test sample results ------------------------------------------------------ 48

    Subsection 8 Microorganisms in stool ----------------------------------------------- 49

    Subsection 9 Conditions for stool rejection ---------------------------------------- 54

    Subsection 10 Blood and stool testing in specific situations ------------------- 54

    Section 11 Microbial control _______________________________________________ 54 Subsection 1 Transport and storage of donated stool prior to processing- 54

    Subsection 2 Validated procedure for processing stool ------------------------- 55

    Subsection 4 Post-processing storage of stool and FMT products ------------ 56

    Appendix 2: Draft Therapeutic Goods (Standard for FMT Products) Order _______________________________ 57

    Part 1 – Preliminary _________________________________________________________ 57 Section 4 Definitions ---------------------------------------------------------------------- 57

    Section 5 Standard ------------------------------------------------------------------------- 59

    Section 6 Application --------------------------------------------------------------------- 59

    Part 2 – General requirements for FMT products _______________________ 59 Section 7 General requirements for all FMT products that are biologicals 59

    Part 3 – Specific requirements for FMT products _______________________ 60 Section 8 Requirements in relation to the medical and social history of prospective stool donors ---------------------------------------------------------------- 60

    Section 9 Requirements in relation to donor blood and stool testing ------- 64

    Section 10 Requirements in relation to donor physical assessment and testing -------------------------------------------------------------------------------------------------- 65

    Section 11 Requirements in relation to microbial control --------------------- 67

  • Therapeutic Goods Administration

    Draft Standards for Faecal microbiota transplant (FMT) products V1.0 November 2019

    Page 5 of 69

    Purpose and scope The purpose of this consultation paper is to outline the proposed standards for faecal microbiota transplant (FMT) products in Australia. Submissions received in response to this consultation will inform the final decision by the Australian Government regarding the most appropriate standards to apply to the therapeutic use of FMT products in Australia. This area will be regulated by the Therapeutic Goods Administration (TGA).

    In this consultation paper, detailed guidance and justification is provided (Appendix 1) on a new draft Therapeutic Goods Order (TGO): Standards for Faecal Microbiota Transplant Products (Appendix 2). This has been provided to assist your review and consideration of the proposed requirements that will apply to all providers of FMT products.

    Note that the versions of the TGO and associated guidance provided in this consultation are not the final versions, and may be subject to change following feedback from this consultation.

    Your input is sought on specific questions raised within the consultation paper, as well as specific feedback on the applicable standards.

    Your views are sought

    TGA invites comments from interested parties. Comments can address any of the issues in this consultation paper.

    To submit, complete the online consultation submission form to upload your submission in either PDF or Microsoft Word format.

    Alternatively, hardcopy submissions with a printed coversheet may be mailed to:

    Biological Science Section Therapeutic Goods Administration PO Box 100 WODEN ACT 2606

    Any questions relating to submissions should be directed to TGA’s Biological Science Section by email to:

    bloodandtissues@health.gov.au

    Alternatively, by telephone to 1800 678 799 (free call within Australia).

    The closing date for comments is COB Friday 31 January 2020.

    Background Faecal microbiota transplant (FMT) is the process of transplanting gut microflora either in human stool or products processed from human stool, from a healthy human donor into the bowel of a recipient with a medical condition. FMT products include fresh or banked human stool that may be introduced to the bowel by rectal enema, sigmoidoscopy,

Recommended

View more >